Revascularization could improve areas traditionally considered necrotic

Original title: Prevalence of Regional Myocardial Thinning and Relationship With Myocardial Scarring in Patients With Coronary Artery Disease. Reference: Dipan J. Shah et al. JAMA. 2013;309(9):909-918

Regional left ventricular (LV) wall thinning is believed to represent chronic myocardial infarction. In fact, the most recent guidelines, both European and American, have concluded that “Images that show regional myocardial thinning in absence of contraction with no other cause than the ischemic, are diagnosed as chronic infarction”. Regional left ventricular (LV) wall thinning is believed to represent chronic myocardial infarction. However, recent case reports using delayed-enhancement cardiovascular magnetic resonance (CMR) imaging raise the possibility that thinning may occur with little or no scarring. 

The recent incorporation of Delayed Enhancement MR imaging to the study of patients with ischemic heart disease could change the previous paradigm. This prospective study included 1055 patients with a history of ischemic heart disease between 2000 and 2008, where diagnosed through 1.5T DE-MR in 1.5T. A ≤ 5.5 mm thinning was considered at the end of diastole. Scarring tissue was also analyzed (hyperintense areas) within thinning. Of 1055 patients analyzed, 201 (19%) had regional wall thinning of some LV area.

Among patients with thinning undergoing revascularization and follow-up CMR (RR=0.72, p<0.001), there was improvement in the systolic global function (RR=0.53, p<0.001) and a reduction in end-diastole volume (RR=0.42, p=0.007). It was also observed that the Q waves disappeared from the ECG. The latter was inversely correlated to scar extent within the thinned region.

Conclusion: 

Among patients with CAD referred for CMR and found to have regional wall thinning, limited scar burden was present in 18% and was associated with improved contractility and resolution of wall thinning after revascularization.

Editorial Comment: 

This study has a major limitation, the decision to revascularize was left to the attending physicians, which could affect selection. These results contradict the present guidelines and paradigmes and require further randomized studies for confirmation. 

SOLACI.ORG

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...